Alerts will be sent to your verified email
Verify EmailFDC
|
FDC
|
Sanofi India
|
Zota Health Care
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Domestic Sales Growth - YoY
|
5.1 % | 1.7 % | n/a |
|
R&D as a % of Total Sales
|
2.22 % | 0.0 | 0.09 % |
|
Financials
|
|||
|
5 yr Average ROE
|
12.9 % | 50.34 % | 1.99 % |
|
5yr average Equity Multiplier
|
1.57 | 5.32 | 1.84 |
|
5yr Average Asset Turnover Ratio
|
0.55 | 0.42 | 0.91 |
|
5yr Avg Net Profit Margin
|
15.2 % | 22.84 % | -4.95 % |
|
Price to Book
|
2.47 | 9.98 | 13.1 |
|
P/E
|
27.7 | 24.14 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-13.89 Days | -15.2 Days | 40.5 Days |
|
Inventory Days
|
61.89 Days | 67.68 Days | 91.82 Days |
|
Days Receivable
|
18.98 Days | 35.69 Days | 42.2 Days |
|
Days Payable
|
89.17 Days | 75.12 Days | 92.36 Days |
|
5yr Average Interest Coverage Ratio
|
90.41 | 777.41 | 5.98 |
|
5yr Avg ROCE
|
13.8 % | 23.73 % | -2.72 % |
|
5yr Avg Operating Profit Margin
|
17.7 % | 25.16 % | 3.69 % |
|
5 yr average Debt to Equity
|
0.0 | 0.0 | 0.04 |
|
5yr CAGR Net Profit
|
-2.41 % | 25.59 % | 206.06 % |
|
5yr Average Return on Assets
|
8.22 % | 9.68 % | -3.4 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.66 % | 60.4 % | 49.38 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.26 % |
|
Change in Promoter Holding (3 Yrs)
|
0.16 % | 0.0 | -18.74 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-1.8 % | -0.27 % | 0.37 % |
|
FDC
|
Sanofi India
|
Zota Health Care
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|